- Home
- SGHT vs ONL Comparison
SGHT vs ONL Comparison
Compare SGHT & ONL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGHT
- ONL
- Stock Information
- Founded
- SGHT 2011
- ONL 2021
- Country
- SGHT United States
- ONL United States
- Employees
- SGHT N/A
- ONL N/A
- Industry
- SGHT Medical Specialities
- ONL Real Estate Investment Trusts
- Sector
- SGHT Health Care
- ONL Real Estate
- Exchange
- SGHT Nasdaq
- ONL Nasdaq
- Market Cap
- SGHT 193.2M
- ONL 169.5M
- IPO Year
- SGHT 2021
- ONL N/A
- Fundamental
- Price
- SGHT $7.17
- ONL $2.43
- Analyst Decision
- SGHT Buy
- ONL Hold
- Analyst Count
- SGHT 8
- ONL 1
- Target Price
- SGHT $4.93
- ONL N/A
- AVG Volume (30 Days)
- SGHT 247.0K
- ONL 210.5K
- Earning Date
- SGHT 11-06-2025
- ONL 11-06-2025
- Dividend Yield
- SGHT N/A
- ONL 3.33%
- EPS Growth
- SGHT N/A
- ONL N/A
- EPS
- SGHT N/A
- ONL N/A
- Revenue
- SGHT $76,052,000.00
- ONL $149,775,000.00
- Revenue This Year
- SGHT N/A
- ONL N/A
- Revenue Next Year
- SGHT $12.04
- ONL N/A
- P/E Ratio
- SGHT N/A
- ONL N/A
- Revenue Growth
- SGHT N/A
- ONL N/A
- 52 Week Low
- SGHT $2.03
- ONL $1.46
- 52 Week High
- SGHT $8.06
- ONL $4.30
- Technical
- Relative Strength Index (RSI)
- SGHT 74.25
- ONL 39.01
- Support Level
- SGHT $4.86
- ONL $2.28
- Resistance Level
- SGHT $8.06
- ONL $2.64
- Average True Range (ATR)
- SGHT 0.43
- ONL 0.11
- MACD
- SGHT 0.19
- ONL -0.00
- Stochastic Oscillator
- SGHT 70.31
- ONL 27.38
About SGHT Sight Sciences Inc.
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.
About ONL Orion Office REIT Inc.
Orion Properties Inc is a internally-managed REIT engaged in the ownership, acquisition, and management of a diversified portfolio of mission-critical and headquarters office buildings located in high quality suburban markets across the U.S. and leased on a single-tenant net lease basis to creditworthy clients. The portfolio of the company includes traditional office buildings, governmental offices, medical offices, laboratories, and others. The Company operates in one business segment: direct ownership and operation of commercial real estate.